First Horizon Advisors’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $45.5K | Buy |
207
+22
| +12% | +$4.7K | ﹤0.01% | 1058 |
|
|
2025
Q1 | $41.4K | Buy |
185
+85
| +85% | +$23.4K | ﹤0.01% | 1019 |
|
|
2024
Q4 | $32.8K | Sell |
100
-14
| -12% | -$4.41K | ﹤0.01% | 1136 |
|
|
2024
Q3 | $34.2K | Buy |
114
+2
| +2% | +$612 | ﹤0.01% | 1161 |
|
|
2024
Q2 | $36.9K | Sell |
112
-58
| -34% | -$20.5K | ﹤0.01% | 1057 |
|
|
2024
Q1 | $67.3K | Buy |
170
+3
| +2% | +$1.11K | ﹤0.01% | 823 |
|
|
2023
Q4 | $58.8K | Buy |
167
+13
| +8% | +$4.6K | ﹤0.01% | 848 |
|
|
2023
Q3 | $57.8K | Buy |
154
+7
| +5% | +$2.71K | ﹤0.01% | 799 |
|
|
2023
Q2 | $56.2K | Hold |
147
| – | – | ﹤0.01% | 840 |
|
|
2023
Q1 | $50.9K | Buy |
147
+40
| +37% | +$11.7K | ﹤0.01% | 871 |
|
|
2022
Q4 | $25.2K | Sell |
107
-19
| -15% | -$4.5K | ﹤0.01% | 1174 |
|
|
2022
Q3 | $30K | Sell |
126
-358
| -74% | -$109K | ﹤0.01% | 1067 |
|
|
2022
Q2 | $146K | Buy |
484
+408
| +537% | +$133K | 0.01% | 538 |
|
|
2022
Q1 | $31K | Sell |
76
-618
| -89% | -$242K | ﹤0.01% | 780 |
|
|
2021
Q4 | $324K | Buy |
694
+27
| +4% | +$11.6K | 0.01% | 425 |
|
|
2021
Q3 | $282K | Sell |
667
-5
| -0.7% | -$2.11K | 0.01% | 443 |
|
|
2021
Q2 | $241K | Buy |
672
+301
| +81% | +$99.5K | 0.01% | 377 |
|
|
2021
Q1 | $104K | Buy |
371
+85
| +30% | +$24.3K | 0.01% | 499 |
|
|
2020
Q4 | $80K | Buy |
286
+60
| +27% | +$16.8K | 0.01% | 482 |
|
|
2020
Q3 | $61K | Buy |
226
+128
| +131% | +$33.9K | ﹤0.01% | 486 |
|
|
2020
Q2 | $22K | Buy |
+98
| New | +$19.3K | ﹤0.01% | 776 |
|
|
2018
Q1 | – | Sell |
-378
| Closed | -$37K | – | 1483 |
|
|
2017
Q4 | $37K | Buy |
378
+13
| +4% | +$1.27K | ﹤0.01% | 609 |
|
|
2017
Q3 | $35K | Hold |
365
| – | – | ﹤0.01% | 597 |
|
|
2017
Q2 | $31K | Sell |
365
-55
| -13% | -$5.06K | ﹤0.01% | 620 |
|
|
2017
Q1 | $38K | Sell |
420
-401
| -49% | -$33.5K | ﹤0.01% | 619 |
|
|
2016
Q4 | $58K | Hold |
821
| – | – | 0.01% | 497 |
|
|
2016
Q3 | $58K | Sell |
821
-236
| -22% | -$18.7K | 0.01% | 490 |
|
|
2016
Q2 | $80K | Sell |
1,057
-91
| -8% | -$6.62K | 0.01% | 429 |
|
|
2016
Q1 | $80K | Buy |
1,148
+133
| +13% | +$8K | 0.01% | 458 |
|
|
2015
Q4 | $61K | Sell |
1,015
-377
| -27% | -$22.7K | 0.01% | 445 |
|
|
2015
Q3 | $75K | Sell |
1,392
-154
| -10% | -$8.97K | 0.01% | 436 |
|
|
2015
Q2 | $89K | Sell |
1,546
-40
| -3% | -$2.23K | 0.01% | 423 |
|
|
2015
Q1 | $94K | Sell |
1,586
-85
| -5% | -$4.53K | 0.01% | 426 |
|
|
2014
Q4 | $89K | Sell |
1,671
-5
| -0.3% | -$250 | 0.01% | 421 |
|
|
2014
Q3 | $75K | Buy |
1,676
+258
| +18% | +$11K | 0.01% | 445 |
|
|
2014
Q2 | $57K | Buy |
1,418
+5
| +0.4% | +$214 | 0.01% | 510 |
|
|
2014
Q1 | $64K | Sell |
1,413
-5
| -0.4% | -$235 | 0.01% | 457 |
|
|
2013
Q4 | $65K | Hold |
1,418
| – | – | 0.01% | 439 |
|
|
2013
Q3 | $58K | Sell |
1,418
-650
| -31% | -$24.8K | 0.01% | 432 |
|
|
2013
Q2 | $73K | Buy |
+2,068
| New | +$68.1K | 0.04% | 179 |
|
Other funds holding WST
First Horizon Advisors's WST Position: Q2 2025 in Review
First Horizon Advisors increased its West Pharmaceutical (WST) stake by 12% in Q2 2025, buying an estimated $4.7K and bringing the position to 207 shares worth $45.5K. The position accounts for ﹤0.01% of the portfolio, ranked #1058.
First Horizon Advisors first reported a position in WST in Q2 2013 and has held it in 40 quarters since. The position peaked at $324K in Q4 2021. 731 funds tracked by Wall St. Rank hold WST as of Q2 2025.
- First Horizon Advisors held 207 shares of West Pharmaceutical worth $45.5K as of Q2 2025.
- First Horizon Advisors bought 22 West Pharmaceutical shares in Q2 2025, an estimated $4.7K.
- West Pharmaceutical made up ﹤0.01% of First Horizon Advisors's portfolio in Q2 2025, its #1058 holding.
- First Horizon Advisors first reported a position in West Pharmaceutical in Q2 2013 and has held it in 40 quarters since.
- First Horizon Advisors's West Pharmaceutical position peaked at $324K in Q4 2021.
- 731 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2025.
Based on First Horizon Advisors's 13F filing for Q2 2025, filed 6 Aug 2025.